Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F2t-Isoprostane (8-iso-PGF2α) by a stable isotope dilution mass spectrometric assay
- 31 December 2001
- journal article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 314 (1-2), 93-99
- https://doi.org/10.1016/s0009-8981(01)00637-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Specific Analysis in Plasma and Urine of 2,3-Dinor-5,6-dihydro-isoprostane F2α-III, a Metabolite of Isoprostane F2α-III and an Oxidation Product of γ-Linolenic AcidPublished by Elsevier BV ,2000
- Quantification of the Major Urinary Metabolite of 15-F2t-Isoprostane (8-iso-PGF2α) by a Stable Isotope Dilution Mass Spectrometric AssayAnalytical Biochemistry, 1999
- THE ISOPROSTANES: UNIQUE PROSTAGLANDIN-LIKE PRODUCTS OF FREE-RADICAL-INITIATED LIPID PEROXIDATION*Drug Metabolism Reviews, 1999
- In Vivo Formation of 8-Epi-Prostaglandin F 2α Is Increased in HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Diastereoselective Synthesis of an Isoprostane: (±)-8-epi-PGF2α Ethyl EsterThe Journal of Organic Chemistry, 1997
- Identification of the Major Urinary Metabolite of the F2-isoprostane 8-Iso-prostaglandin F2α in HumansJournal of Biological Chemistry, 1996
- 8‐Epi PGF2α: specific analysis of an isoeicosanoid as an index of oxidant stress in vivoBritish Journal of Clinical Pharmacology, 1996
- Oxidative stress status: An introductionFree Radical Biology & Medicine, 1991